Food Selection — Evaluation of a Healthy Food Procurement Policy at Municipality-level in Nepal
Citation(s)
Amoroso L The Second International Conference on Nutrition: Implications for Hidden Hunger. World Rev Nutr Diet. 2016;115:142-52. doi: 10.1159/000442100. Epub 2016 May 19.
Dhungana RR, Thapa P, Devkota S, Banik PC, Gurung Y, Mumu SJ, Shayami A, Ali L Prevalence of cardiovascular disease risk factors: A community-based cross-sectional study in a peri-urban community of Kathmandu, Nepal. Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S20-S27. doi: 10.1016/j.ihj.2018.03.003. Epub 2018 Mar 10.
Diseases N Global Action Plan for the Prevention and Control of NCDs 2013-2020. World Health Organization; 14 Nov 2013 [cited 11 Oct 2022]. Available: https://www.who.int/publications/i/item/9789241506236
Vandevijvere S, Chow CC, Hall KD, Umali E, Swinburn BA Increased food energy supply as a major driver of the obesity epidemic: a global analysis. Bull World Health Organ. 2015 Jul 1;93(7):446-56. doi: 10.2471/BLT.14.150565.
Winson A School Food Environments and the Obesity Issue: Content, Structural Determinants, and Agency in Canadian High Schools. 2008 [cited 11 Oct 2022].
Develop, Implement and Evaluate a Public Food Procurement Policy in Nepal
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
